{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"crigler-najjar-syndrome-type-2","columns":[{"gene":"","key":"population-ced48165129e25fc023f","label":"Crigler-Najjar syndrome, type II","mondoId":"MONDO:0011725","onsetQualifier":null,"originColumnKey":"MONDO:0011725/OMIM:606785","originalViews":[{"key":"MONDO:0011725/OMIM:606785","label":"Crigler-Najjar syndrome, type II","scopeLabel":"OMIM:606785","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0ef4357c0241fec8aba4fa71164f1310fec90c4c1455142946a387872402faa4","30b4083cdec2a4f7b8c21d4605de8a377f6c18849b5b9bffe592f2b8a37ecdb0","f4d1bce951f55c963c46bc70bdb58e4a153dd862d7c11600117df1f646b45dab","f83ae9ca4598ccc0e8856fd0c0f5d18bcb1da0b3c89183ca5105a45823634999"],"recordQualifiers":{},"scopeLabel":"OMIM:606785","sourceIds":["OMIM:606785"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-139e21f948f3ae646ad9","label":"Crigler-Najjar syndrome type 2","mondoId":"MONDO:0011725","onsetQualifier":null,"originColumnKey":"MONDO:0011725/ORPHA:79235","originalViews":[{"key":"MONDO:0011725/ORPHA:79235","label":"Crigler-Najjar syndrome type 2","scopeLabel":"ORPHA:79235","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["9b0cb2a54c0fa46009d41cbe2f373c56563ef6b3be60eb6b90fbcf8c00be8187","b217010cc7e836d62bd7593e671165c5b1f776e7dfe7ae234af558d60ddbe021","e9ca9b19aaa7deb7fe7fec82da3c41b1ce4baaf562393229bc23d6e106443ac7"],"recordQualifiers":{},"scopeLabel":"ORPHA:79235","sourceIds":["ORPHA:79235"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ced48165129e25fc023f","population-139e21f948f3ae646ad9"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002910","HP:0000952","HP:0003265","HP:0006579","HP:6000617","HP:0008282"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":7,"sourceGroups":{"orphanet":3,"published":4}},"features":[{"hpoId":"HP:0002910","label":"Elevated circulating hepatic transaminase concentration","primary":true},{"hpoId":"HP:0000952","label":"Jaundice","primary":true},{"hpoId":"HP:0003265","label":"Neonatal hyperbilirubinemia","primary":true},{"hpoId":"HP:0006579","label":"Prolonged neonatal jaundice","primary":true},{"hpoId":"HP:6000617","label":"Reduced tissue UDP-glucuronyl-transferase activity","primary":true},{"hpoId":"HP:0008282","label":"Unconjugated hyperbilirubinemia","primary":true}],"ledeHtml":"Type 2 Crigler-Najjar syndrome (CNS2) is a hereditary disorder of bilirubin metabolism characterized by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). CNS2 is a milder form of CNS than CNS1.","mondoId":"MONDO:0011725","node":{"canonicalSlug":"crigler-najjar-syndrome-type-2","comparisons":[{"documentSha256":"f977e5d958397beb17aa77c3330230bbff889578d49074ce64fb2ba3dbc80e23","key":"legacy-crigler-najjar","kind":"legacy","label":"Crigler-Najjar syndrome","memberIds":["MONDO:0009044","MONDO:0011725","MONDO:0021020"],"mondoId":"MONDO:0009044","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/crigler-najjar.f977e5d958397beb17aa77c3330230bbff889578d49074ce64fb2ba3dbc80e23.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"Crigler-Najjar syndrome type 2","paragraphs":["Type 2 Crigler-Najjar syndrome (CNS2) is a hereditary disorder of bilirubin metabolism characterized by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). CNS2 is a milder form of CNS than CNS1."],"scope":"exact","source":"MONDO","upstream":"Orphanet:79235","url":"https://monarchinitiative.org/MONDO:0011725"},"ownColumnKeys":["population-ced48165129e25fc023f","population-139e21f948f3ae646ad9"],"publication":"published","relationships":[{"kind":"parent","label":"Crigler-Najjar syndrome","mondoId":"MONDO:0009044","slug":"crigler-najjar"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/8683"}],"translation":"published"},"records":[{"frequencyKind":"count","key":"0ef4357c0241fec8aba4fa71164f1310fec90c4c1455142946a387872402faa4","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:606785","disease_name":"Crigler-Najjar syndrome, type II","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0000952","is_excluded":false,"label":"Jaundice","onset_id":null,"reference":"PMID:9621515","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"30b4083cdec2a4f7b8c21d4605de8a377f6c18849b5b9bffe592f2b8a37ecdb0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606785","disease_name":"Crigler-Najjar syndrome, type II","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:6000617","is_excluded":false,"label":"Reduced tissue UDP-glucuronyl-transferase activity","onset_id":null,"reference":"PMID:7989595","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"9b0cb2a54c0fa46009d41cbe2f373c56563ef6b3be60eb6b90fbcf8c00be8187","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79235","disease_name":"Crigler-Najjar syndrome type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003265","is_excluded":false,"label":"Neonatal hyperbilirubinemia","onset_id":null,"reference":"ORPHA:79235","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b217010cc7e836d62bd7593e671165c5b1f776e7dfe7ae234af558d60ddbe021","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79235","disease_name":"Crigler-Najjar syndrome type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008282","is_excluded":false,"label":"Unconjugated hyperbilirubinemia","onset_id":null,"reference":"ORPHA:79235","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e9ca9b19aaa7deb7fe7fec82da3c41b1ce4baaf562393229bc23d6e106443ac7","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79235","disease_name":"Crigler-Najjar syndrome type 2","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0006579","is_excluded":false,"label":"Prolonged neonatal jaundice","onset_id":null,"reference":"ORPHA:79235","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"f4d1bce951f55c963c46bc70bdb58e4a153dd862d7c11600117df1f646b45dab","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606785","disease_name":"Crigler-Najjar syndrome, type II","evidence":"PCS","frequency_raw":"8/8","hpo_id":"HP:0008282","is_excluded":false,"label":"Unconjugated hyperbilirubinemia","onset_id":null,"reference":"PMID:8276413;PMID:9621515","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f83ae9ca4598ccc0e8856fd0c0f5d18bcb1da0b3c89183ca5105a45823634999","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606785","disease_name":"Crigler-Najjar syndrome, type II","evidence":"PCS","frequency_raw":"0/7","hpo_id":"HP:0002910","is_excluded":true,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"PMID:9621515","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011725\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:79235</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Type 2 Crigler-Najjar syndrome (CNS2) is a hereditary disorder of bilirubin metabolism characterized by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). CNS2 is a milder form of CNS than CNS1.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011725\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"crigler-najjar-syndrome-type-2","sourceDocuments":[{"name":"MONDO: Crigler-Najjar syndrome type 2","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011725"}],"sourceNote":"","synonyms":["Arias syndrome","bilirubin uridinediphosphate glucuronosyltransferase deficiency type 2","bilirubin-UGT deficiency type 2","Crigler Najjar syndrome, type 2","hereditary unconjugated hyperbilirubinemia type 2","UGT deficiency type 2"],"takeawayHtml":"","title":"Crigler-Najjar syndrome type 2"},"schemaVersion":1}
